Comparative radical scavenging ability of bidentate iron(III) chelators

Biochemical Pharmacology

Volumn 55, Issue 8, 1998, Pages 1327-1332

  Kayyali, Reem ^a   Pannala, Ananth Sekher ^a   Khodr, Hicham ^a   Hider, Robert C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Hydroxypyridinones; Hydroxyurea; Iron chelators; Radical scavengers

Indexed keywords

1 CARBOXYMETHYL 3 HYDROXYPYRIDIN 2 ONE; 3 HYDROXY 2 PYRIDONE DERIVATIVE; 3 HYDROXY 4 PYRIDONE DERIVATIVE; 8 QUINOLINOL; ACETOHYDROXAMIC ACID; CP 08; DEFERIPRONE; DEFEROXAMINE; FERRIC ION; FREE RADICAL; HYDROXYUREA; IRON; IRON CHELATE; MALTOL; PHENOL; PYRIDONE DERIVATIVE; SCAVENGER; UNCLASSIFIED DRUG;

ARTICLE; CELL DAMAGE; DRUG MECHANISM; ENZYME ACTIVE SITE; HEART INFARCTION; IRON CHELATION; ISCHEMIA; NERVE DEGENERATION; OXIDATIVE STRESS; PRIORITY JOURNAL; STROKE;

EID: 0032523110     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00602-3     Document Type: Article

References (31)

1. Aust SD, White BC. Iron chelation prevents tissue injury following ischaemia. Adv Free Rad Biol Med. 1:1985;1-17.
2. Sempos CT, Looker AC, Gillum RF. Iron and heart disease the epidemiologic data . Nut Rev. 54:1996;73-84.
3. Komara JS, Nayini NR, Bialick HA, Indrien RJ, Evans AT, Garritano AM, Hoehner TJ, Jacobs WA, Huang RR, Krause GS, White BC, Aust SD. Brain iron delocalisation and lipid peroxidation following cardiac arrest. Ann Emerg Med. 15:1986;384-389.
4. Reddy BR, Kloner RA, Przyklenk K. Early treatment with deferoxamine limits myocardial ischaemic/reperfusion injury. Free Rad Biol Med. 7:1989;45-52.
5. Gerlach M, Ben-Shachar D, Riederer P, Youdim MBH. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem. 63:1994;793-807.
6. Hider RC, Singh S, Porter JB. Iron chelators with clinical potential. Proc Royal Soc Edin. 99B:1992;137-168.
7. Halliwell B. Use of desferrioxamine as a probe for iron-dependent formation of hydroxyl radicals. Biochem Pharmacol. 34:1985;229-233.
8. Morehouse KM, Flitter WD, Mason RP. The enzymatic oxidation of Desferal to a nitroxide free radical. FEBS Letts. 222:1987;246-250.
9. van der Kraaij AMM, van Eijk HG, Koster JF. Prevention of postischaemic cardiac injury by the orally active iron chelator 1,2-dimethyl-3-hydroxy-4-pyridinone (L1) and the antioxidant (+)cyanidanol-3. Circulation. 80:1989;158-164.
10. Porter JB, Gyparaki M, Burke LC, Huehns ER, Sarpong P, Saez V, Hider RC. Iron mobilization from hepatocyte monolayer cultures by chelators The importance of membrane permeability and the iron-binding constant . Blood. 72:1988;1497-1503.
11. Morel I, Cillard J, Lescoat G, Sergent O, Pasdeloup N, Ocaktan AZ, Abdallah MA, Brissot P, Cillard P. Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones of iron-loaded heptocyte cultures comparison of their mechanism of protection with that of desferrioxamine . Free Rad Biol Med. 13:1992;499-508.
12. Hewitt SD, Hider RC, Sarpong P, Morris CJ, Blake DR. Investigation of the anti-inflammatory properties of hydroxypyridinones. Ann Rheumat Dis. 48:1989;382-388.
13. Dobbin PS, Hider RC, Hall AD, Taylor PD, Sarpong P, Porter JB, Xiao G, van der Helm D. Synthesis, physicochemical properties and biological evaluation of N-substitute 2-alkyl-3-hydroxypyridinones Orally active iron chelators with clinical potential . J Med Chem. 36:1993;2448-2458.
14. Streater M, Taylor PD, Hider RC, Porter JB. Novel 3-hydroxypyridinones. Synthesis, iron(III) chelating properties and biological activity. J Med Chem. 33:1990;1749-1755.
15. Kato K, Terao S, Shimamoto N, Hirata M. Studies on scavengers of active oxygen species. 1. Synthesis and biological activity of 2-O-alkylascorbic acids. J Med Chem. 31:1988;793-798.
16. Rekka E, Kourounakis PN. Effect of hydroxylethyl rutosides and related compounds on lipid peroxidation and free radical scavenging activity. Some structural aspects. J Pharm Pharmacol. 43:1991;486-491.
17. Singh S, Hider RC. Colorimetric detection of the hydroxyl radical comparison of the hydroxyl-radical-generating ability of various iron complexes . Anal Biochem. 171:1988;47-54.
18. Pannala AS, Halliwell B, Rice-Evans CA, Singh S. Inhibition of peroxynitrite-mediated-tyrosine nitration by catechin polyphenols. Biochem Biophys Res Comm. 232:1997;164-168.
19. Pannala AS, Razaq R, Halliwell B, Singh S and Rice-Evans CA, Inhibition of peroxynitrite dependent tyrosine nitration by hydroxyannamates: nitration or electron donation? Free Rad Biol Med, 1998 (in press).
20. Hess KM, Dix TA. Evaluation of N-hydroxy-2-thiopyridone as a nonmetal dependent source of the hydroxyl radical in aqueous systems. Anal Biochem. 206:1992;309-314.
21. Taylor PD, Morrison IEG, Hider RC. Microcomputer application of non-linear regression analysis to metal-ligand equilibria. Talanta. 35:1988;507-512.
22. Gran G. Determination of the equivalence point in potentiometric titrations. Analyst. 73:1952;661-671.
23. Taylor PD, Iron(III) Hydroxypyridinone Equilibria. Essex University, 1986, PhD Thesis.
24. Hider RC, Hall AD. Clinically useful chelators of tripositive elements. Prog Med Chem. 28:1991;41-173.
25. Hider RC, Choudhury R, Rai BH, Dehkordi LS, Singh S. Design of orally active iron chelators. Acta Haematol. 95:1996;6-12.
26. Davies MJ, Donkor R, Dunster CA, Gee CA, Jonas S, Willson RL. Desferrioxamine and superoxide free radicals. Biochem J. 246:1987;725-729.
27. 2 from ribonucleotide reductase with hydroxyurea. Biochem Biophys Res Comm. 188:1992;879-887.
28. Brooks CDW, Stewart AO, Basha A, Bhatia P, Ratajczyk JD, Martin JG, Craig RA, Kolasa T, Bouska JB, Lanni C, Harris RR. [(4-Fluorophenyl)methyl]-2-thienyl-1-methyl-2-propynyl-N-hydroxyurea, a second generation 5-lipoxygenase inhibitor. J Med Chem. 38:1995;4768-4775.
29. 1HNMR spectroscopy and x-ray crystallography. J Chem Soc Perk Trans 451-455, 1993.
30. Abeysinghe RC, Roberts PJ, Cooper CE, MacLean KH, Hider RC, Porter JB. The environment of the lipoxygenase iron binding site explored with novel hydroxypyridinone iron chelators. J Biol Chem. 271:1996;7965-7972.
31. Cooper CE, Lynagh GR, Hoyes KP, Hider RC, Cammack R, Porter JB. The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase. J Biol Chem. 271:1996;20291-20299.